Dataset Information


Toxoplasma gondii soluble tachyzoite antigen triggers protective mechanisms against fatal intestinal pathology in oral infection of C57BL/6 mice.

ABSTRACT: Toxoplasma gondii induces a potent IL-12 response early in infection that results in IFN-?-dependent control of parasite growth. It was previously shown that T. gondii soluble tachyzoite antigen (STAg) injected 48 hr before intraperitoneal infection reduces lipoxin A4 and 5-lipoxygenase (5-LO)-dependent systemic IL-12 and IFN-? production as well as hepatic immunopathology. This study investigated the ability of STAg-pretreatment to control the fatal intestinal pathology that develops in C57BL/6 mice orally infected with 100 T. gondii cysts. STAg-pretreatment prolonged the animals' survival by decreasing tissue parasitism and pathology, mainly in the ilea. Protection was associated with decreases in the systemic IFN-? levels and IFN-? and TNF message levels in the ilea and with increased TGF-? production in this tissue, but protection was independent of 5-LO and IL-4. STAg-pretreatment decreased CD4(+) T cell, NK cell, CD11b(+) monocyte and CD11b(+)CD11c(+) dendritic cell numbers in the lamina propria and increased CD8(+) T cells in the intestinal epithelial compartment. In parallel, decreases were observed in iNOS and IL-17 expression in this organ. These results demonstrate that pretreatment with STAg can induce the recruitment of protective CD8(+) T cells to the intraepithelial compartment and decrease proinflammatory immune mechanisms that promote intestinal pathology in T. gondii infection.

SUBMITTER: Benevides L 

PROVIDER: S-EPMC3782460 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3957979 | BioStudies
2019-01-01 | S-EPMC6528702 | BioStudies
2015-01-01 | S-EPMC4610860 | BioStudies
2016-01-01 | S-EPMC4801902 | BioStudies
2011-01-01 | S-EPMC3118864 | BioStudies
2015-01-01 | S-EPMC4487685 | BioStudies
2020-01-01 | S-EPMC7403597 | BioStudies
2013-01-01 | S-EPMC3795032 | BioStudies
2012-01-01 | S-EPMC3436937 | BioStudies
2018-01-01 | S-EPMC6179443 | BioStudies